Member Info for StarBright

Dobbo777, you can apply Occam's razor to this. The simplest explanation is generally the right one. With this share there are sellers (visible daily on this board exhorting you to buy..!) who've profited from the rise since July but are still unloading into any positive spikes. So the spikes aren't lasting long. It's convenient/fortunate for the sellers that there is such a supply of minor RNS's to keep the wheel spinning...

Do you mean someone to market the company's shares to investors, or its products to customers?

Two very different roles / skillsets.

All your worst traits in one succinct post.

Becoming a PLC doesn't mean they are going public (as in shares listed on an exchange). That is an entirely different matter.

I am quite sure that the reason for the apparent delay in MHRA approval is that our government don't want home testing kits available to all. From a government perspective, three problems would be created:

1. People who have positive antibody tests might be less inclined to obey lockdown rules
2. Home testing with immediate results doesn't support the centralised collection of statistics
3. Home test results wouldn't be visible to Track & Trace

Home antibody testing hands control and data to individuals. This isn't in line with contemporary government policy. Therefore the application has quietly been placed in the long grass. Very short-sighted, and very frustrating.

It's not new news though. I think it's been widely understood & discussed here since September even if the daily bleating for an MHRA RNS continues unabated. Posters waiting for MHRA approval (because they think antibody LFT kits will sell like hot cakes on Amazon) will continue to be disappointed. My expectation is that even if/when MHRA approval is given, it will be accompanied by meaningful restrictions designed to ensure that central control of testing outcomes and stats is retained. These restrictions will be explained in "for the common good" language.

The test kits Omega can produce will all be used however. Just not in the way some here continue to envisage.

MB: “It is the best performing covid lateral flow test on the globe”

Is that a fact? Is there any way to evidence such a statement?

Having had a quick look at Twitter it’s obvious that there is a somewhat febrile atmosphere around ODX (& other testing companies) today.

For those able/looking to increase exposure a good plan might be to set limit orders at (say) 10% and/or 20% below the current SP. That way if there is a tree shake you can be positioned to benefit with the MM’s rather than trying to trade against them.

Who says there’s going to be an announcement at 09:15....?

The Q&A document looks like another honest effort from ODX to me. They are very patient and diligent with their PI investors - with good reason. I agree that it would have been good to see it earlier, but there’s a lot of detail there and careful work will have been required to assemble the all the answers. We could have had a more perfunctory document more quickly, but what we’ve got is in keeping with the company’s style. I think that’s ok.

If we hadn’t had the Pfizer announcement (and subsequent sp reaction) I don’t think we would be having this conversation!

“...clear the day traders and off we go.”

When did you ever see that happen?

Thank you. In that case the additional stake is not “new news” so already in the price. In theory at least!

I suspect/hope that someone better researched than me will post a response here, perhaps about the terms of the original earn-in agreement.

My point is just that it is hard to evaluate whether the additional % is good or bad if you don’t know what it cost..!

Pawnking1 - there is however a critical difference between keeping investors informed and reacting to exogenously driven SP movements. Posters in this thread are looking simply for the company to “do something” after the sp has fallen in recent days. That’s not the role of IR, as I suspect you understand.

The slightly curiously worded RNS doesn’t seem to include detail on what Thor has paid for the additional holding. It says the company has paid the final ($185k of $400k) tranche of the agreement, and has then provided notice to ECL to exercise its right to increase its holding (to30%). Are we to assume that the increase is free? If not, why wasn’t it just included in the original %? Odd.

Too much poor understanding and misplaced irritation here. The company continues to focus on manufacturing diagnostics, rather than on pandering to nervous investors. That’s fine with me.

Calm down! These shares - presumably part of his remuneration - were sold under a pre-determined plan, so the sale was committed to long long before the vaccine results were known. The sale tells us nothing about his faith in either Pfizer’s stock or its vaccine. Not a pump & dump at all.

I’m not sure I agree with that. The sp has traded in a relatively tight range for the last 3 or so weeks. There was no new news today, just confirmation that everything is progressing smoothly. Nothing that wasn’t already in the price. We’ve seen some volatility in PM prices, but in truth gold is not far from where it was 3 weeks ago either.

New news is needed, and the activities underway mean there’s plenty of scope for that in the next few months. Until then, patience.

NT = Negotiated Trade

It means you won't get filled at whatever price you think is being shown.

https://twitter.com/PriapusIQ/status/1325891664741797888

100% agreed.